BioIndustry Review: Australia and New Zealand
The No. 1 source of information on the biotechnology and medical device markets in Australia and New Zealand.
The BioIndustry Review is a clear and concise, independent report summarising the current state of the life sciences industry. This annual publication is a superior source of information for:
- understanding the biotechnology and medical devices industries;
- maintaining awareness of the latest industry trends and emerging markets;
- following listed company developments, funding and value;
- finding new unlisted private companies;
- identifying key players in the Australian and New Zealand markets;
- tracking the contribution of public sector R&D to industry development; and
- keeping abreast of regulatory changes and their effects on the industry.
Biotechnology is a complex and dynamic industry based in science and technology. If you’re looking for a quick and easy way to increase your knowledge of the life sciences market, then the BioIndustry Review is for you.
What is the BioIndustry Review?
The BioIndustry Review: Australia and New Zealand is an independent report, published annually, describing and analysing the state and trends of the bioindustry in Australia and New Zealand. The authors, Drs Lyndal Thorburn and Kelvin Hopper of Innovation Dynamics, are highly regarded in the biotechnology sector and have been publishing the BioIndustry Review since 2001.
The BioIndustry Review: Australia and New Zealand includes data and statistics on public and private biotechnology and medical device companies in Australia and New Zealand, as well as analyses of research and financing trends in the bioindustry. Each year the report contains new and exclusive information on unlisted companies, and follows major regulatory changes and Federal and State Government funding and activity.
